GenVec IncAdd to My Watchlist

GNVC:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 0.63
    Last
  • 0.05  -7.28%
    Today's Change
  • 0.68
    Previous Close
  • Today
     
    0.35
    3.69
    52 Week Low - High
8:10 pm ET 5/27/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding23 million
Market Cap$14 million
Return on Equity ttm-76.41%
Last DividendGNVC:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.410
EPS: Year Est. 12/16 ttm--
 
EPS: Quarterly Actual 3/16 -0.11
EPS: Quarterly Est. 6/16 --
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-143.75
Company Description
GenVec Inc. is a clinical-stage biopharmaceutical focused on leveraging its proprietary adenovector gene delivery platform to develop a pipeline of cutting-edge therapeutics and vaccines. The Company's lead product is involved in studies involving hearing loss and balance disorders. GenVec also focuses on licensing opportunities of its proprietary vectors and production cell lines.
Revenue$885,000
Net Income$-7 million
Total Assets$9 million
Employees15
Web Sitewww.genvec.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!